• Product NameDarunavir?Ethanolate
• Brief DescriptionInhibitors
• Purification99.68%
• Biological ActivityDarunavir Ethanolate (DRV) is a nonpeptidic?HIV protease?inhibitor, used to treat HIV infection.
• Target NameHIV Protease inhibitor
• CAS No. 635728-49-3
• Calculated MW 593.74
• Formulation C29H43N3O8S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CCO.CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:WT HIV-1 protease
  Boling pt:
  Melting pt:
  Solubility:DMSO: 100 mg/mL (168.42 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Fujimoto H, et al. Biol Pharm Bull, 2009, 32(9), 1588-1593.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting